Cinacalcet in the treatment of intractable hypercalcemia following two neck exploration surgeries for primary hyperparathyroidism

Southern Medical Journal

Volumn 103, Issue 3, 2010, Pages 272-275

  Padmanabhan, Hema ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cinalcet; Hypercalcemia; Hyperparathyroidism

Indexed keywords

CINACALCET;

AGED; ANAMNESIS; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; HEAD AND NECK SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; HYPERCALCIURIA; HYPOPHOSPHATEMIA; MALE; PARATHYROID ADENOMA; PARATHYROID GLAND; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; PRIMARY HYPERPARATHYROIDISM;

AGED, 80 AND OVER; BIOMIMETIC MATERIALS; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; MALE; NAPHTHALENES; PARATHYROID NEOPLASMS; RECEPTORS, CALCIUM-SENSING;

EID: 77949398786     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181ce0f30     Document Type: Article

References (9)

1. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and Disorders of Mineral Metabolism, in Larsen PR, Kronenberg HM, Melmed S, et al (eds): Williams Textbook of Endocrinology. Philadelphia, PA, Saunders, 2003, ed 10, pp 1303-1371.
2. Farford B, Presutti RJ, Moraghan TJ. Nonsurgical management of primary hyperparathyroidism. Mayo Clin Proc 2007;62:351-355.
3. Wü thrich RP, Martin D, Bilezikian JP. The role of calcimimetics in the treatment of hyperparathyroidism. Eur J Clin Invest 2007;37:915-922.
4. Byrnes CA, Shepler BM. Cinacalcet: a new treatment for secondary hyperparathyroidism in patients receiving hemodialysis. Pharmacotherapy 2005;25:709-716.
5. Lindberg JS, Culleton B, Wong G, et al. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis; a randomized, double-blind, multicenter study. J Am Soc Nephrol 2005;16:800-807.
6. Torres PU. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease. J Ren Nutr 2006;16:253-258.
7. Silverberg SJ, Rubin MR, Faiman C, et al. Cinacalcet hydrochloride reduces the serum calcium concentrations in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 2007;92:3803-3808.
8. Shoback DM, Bilezikian JP, Turner SA, et al. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab 2003;88:5644-5649.
9. Peacock M, Bilezikian JP, Klassen PS, et al. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2005;90:135-141.